Alexander K. Yuile

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Clinical outcomes and management of CDKN2A/B homozygously deleted IDH-mutant astrocytomas-a cohort study and patterns of care survey.

Clinical outcomes and management of CDKN2A/B homozygously deleted IDH-mutant astrocytomas-a cohort study and patterns of care survey.

Journal: Neuro-oncology practice
Published: October 13, 2025

Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours.

Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours.

Journal: Journal of neuro-oncology
Published: September 02, 2025

Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions.

Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions.

Journal: Cancers
Published: July 03, 2025

Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination.

Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination.

Journal: NPJ vaccines
Published: June 02, 2025

A protocol for pre-treatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions - a retrospective cohort review.

A protocol for pre-treatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions - a retrospective cohort review.

Journal: Cancer treatment and research communications
Published: April 10, 2025

A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours.

A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours.

Journal: Cancer medicine
Published: February 14, 2025

The APPLE's core question-upfront osimertinib versus the sequential approach for EGFR mutated non-small cell lung cancer.

The APPLE's core question-upfront osimertinib versus the sequential approach for EGFR mutated non-small cell lung cancer.

Journal: Journal of thoracic disease
Published: December 20, 2024

Therapeutic drug monitoring of osimertinib in EGFR mutant non-small cell lung cancer by dried blood spot and plasma collection: A pilot study.

Therapeutic drug monitoring of osimertinib in EGFR mutant non-small cell lung cancer by dried blood spot and plasma collection: A pilot study.

Journal: British journal of clinical pharmacology
Published: October 30, 2023

CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review.

CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review.

Journal: Current issues in molecular biology
Published: May 31, 2023

Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis.

Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis.

Journal: Biomedicines
Published: May 15, 2023

Volumetric response and pattern of failure of histone altered high grade glioma in adults following management with radiation therapy.

Volumetric response and pattern of failure of histone altered high grade glioma in adults following management with radiation therapy.

Journal: Journal of neuro-oncology
Published: March 21, 2023

PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma.

PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma.

Journal: Biomedicines
Published: March 16, 2023
Showing 1-12 of 18

Last Updated: 09/26/2026